Havens Advisors’s Entellus Medical, Inc. Common Stock ENTL Stock Holding History

Havens Advisors’s Portfolio ENTL Stock Details ENTL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-69,028	Closed	-$1.68M	–	34
2017 Q4	$1.68M	Buy	+69,028	New	+$1.33M	1.27%	19

Havens Advisors's ENTL Position: Q1 2018 in Review

Havens Advisors sold out of Entellus Medical, Inc. Common Stock (ENTL) in Q1 2018, closing a stake of 69,028 shares — an estimated $1.68M sold.

Havens Advisors first reported a position in ENTL in Q4 2017 and held it in 1 quarter. The position peaked at $1.68M in Q4 2017. 0 funds tracked by Wall St. Rank hold ENTL as of Q1 2018.

Havens Advisors reported no remaining Entellus Medical, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Havens Advisors sold 69,028 Entellus Medical, Inc. Common Stock shares in Q1 2018, an estimated $1.68M.
Havens Advisors first reported a position in Entellus Medical, Inc. Common Stock in Q4 2017 and held it in 1 quarter.
Havens Advisors's Entellus Medical, Inc. Common Stock position peaked at $1.68M in Q4 2017.
0 funds tracked by Wall St. Rank held Entellus Medical, Inc. Common Stock as of Q1 2018.

Based on Havens Advisors's 13F filing for Q1 2018, filed 17 Apr 2018.